Filing Details
- Accession Number:
- 0001209191-19-011376
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-19 20:22:15
- Reporting Period:
- 2019-02-15
- Accepted Time:
- 2019-02-19 20:22:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187716 | D Ph Lake Mary Polan | 12544 High Bluff Drive, Suite 200 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-02-15 | 13,772 | $65.12 | 23,656 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The weighted average sale price for these transactions was $65.12375 per share, with a range of $64.22 to $66.17. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.